top of page

2024 Speakers Line-up

Sort alphabetically by last name 

Nazif Alic.jpg

Nazif Alic

Professor of Ageing and Gene Regulation, UCL

Prof Nazif Alic's work aims to understand how fine-tuning gene expression can optimise animal physiology for healthy ageing. He uses the fruit fly as the model organism and his research interests span several components of the transcriptional machinery: from the basic apparatus to specialised transcription factors.

Vera Gorbunova

Professor, University of Rochester

Co-director, Rochester Aging Research Center

Dr. Gorbunova is an endowed Professor of Biology at the University of Rochester and a co-director of the Rochester Aging Research Center. Her research is focused on understanding the mechanisms of longevity and genome stability and on the studies of exceptionally long-lived mammals. She has more than 100 publications including publications in high profile journals such as Nature, Science and Cell. Her work received awards from the Ellison Medical Foundation, the Glenn Foundation, American Federation for Aging Research, and from the National Institutes of Health.

vera.png
Barry Halliwell.jpg

Barry Halliwell

Senior Advisor, Academic Appointments and Research Excellence, Office of the Provost
Distinguished Professor, Department of Biochemistry, NUS

Professor Halliwell graduated from Oxford University with BA (first class honours) and D.Phil degrees and holds a Doctor of Science (DSc) degree from the University of London. He was a faculty member with King’s College University of London (1974-2000) and held a prestigious Lister Institute Research fellowship. He was a Visiting Research Professor at the University of California Davis and Berkeley (1995-1999). He now holds several key positions in Singapore.

 

He is recognized for his pioneering work on the role of free radicals and antioxidants in biology, being one of the world’s most highly-cited scientists (Hirsch-Index of 171) and was chosen as a Citation Laureate (2021) for pioneering research in free-radical chemistry including the role of free radicals and antioxidants in human disease. The distinction is awarded by Clarivate to researchers whose work is deemed to be of “Nobel Class” as they are among the most influential, even transformative, in their fields. He was one of 16 scientists (three only in Chemistry) in the 2021 Hall of Citation Laureates.

 

His research focuses on the role of free radicals and antioxidants in human disease, particularly Alzheimer's and other neurodegenerative diseases, identifying novel approaches to delay or prevent such diseases.

Brian Kennedy

Co-Director of the Centre for Healthy Longevity at the National University Health System

 

Dr. Brian Kennedy is internationally recognized for his research in the basic biology of aging and as a visionary committed to translating research discoveries into new ways of detecting, delaying, preventing, and treating human aging and associated diseases. He is a Distinguished Professor in the Department of Biochemistry and Physiology at the Yong Loo Lin School of Medicine at the National University of Singapore. He also serves as the Programme Director for the Healthy Longevity Translational Research Programme and holds the role of Co-Director at the Centre for Healthy Longevity in the National University Health System.

Brian Kennedy_副本.jpg
longo.jpg

Valter Longo

Edna Jones Professor, USC Davis School of Gerontology

Director, USC Longevity Institute

Group Leader, IFOM Cancer Research Institute

 

Dr. Valter Longo studies the fundamental mechanisms of aging in yeast, rodents and humans by using genetics and biochemistry techniques. The focus is on the nutrient-response signal transduction pathways that regulate disease and longevity. This work led to the discovery of the effects of periodic fasting and fasting mimicking diets on multi-system stem cell activation and regeneration in mice, and to clinical trials on a range of age-related diseases.

Yuxuan Lu

Research Assistant Professor, Institute of Advanced Biotechnology, Southern University of Science and Technology, China

Guest Researcher, Max Planck Institute for Biology of Ageing, Germany

Dual Fellow of European EMBO and Marie Curie

Recipient of the "European Future Research Leader" award by the EU

Granted the title "German Talent" by official portal of the German Foreign Office

 

He previously worked in Germany with internationally renowned expert Professor Linda Partridge, founding director of the Max Planck Institute for Biology of Ageing and Vice-President of the British Royal Society. Over the past five years, he has published articles in journals such as Nature, Nature Aging (2), eLife, and PNAS. His "Rapamycin Anti-Ageing Trilogy" research was recognised as a breakthrough and selected as one of the few Research highlights in the Max Planck Society in 2022.

 

He serves as a reviewer for several internationally renowned journals, including eLife, EMBO reports, and Science Advances. Moreover, he led a team that won the Longhack Longevity Startup Competition in 2022. Subsequently, he co-founded and developed the #FlyScreen startup project, focusing on discovering new compounds to cure age-related diseases. These projects are now officially financially supported by the Max!mize incubator at Max Planck Innovation.

He formally returned to China at the beginning of 2024 to join the Southern University of Science and Technology in Shenzhen.

吕.png
RICHARD A. MILLER.JPG

Richard A. Miller

Professor of Pathology, University of Michigan

Richard A. Miller, M.D., Ph.D., is a Professor of Pathology at the University of Michigan, and the Director of Michigan's Paul F. Glenn Center for Biology of Aging Research. He received the BA degree in 1971 from Haverford College, and MD and PhD degrees from Yale University in 1976-1977. After postdoctoral studies at Harvard and Sloan-Kettering, he moved to Boston University in 1982 and then to his current position at Michigan in 1990.

 

Dr. Miller has served in a variety of editorial and advisory positions on behalf of the American Federation for Aging Research and the National Institute on Aging, and served as one of the Editors-in-Chief of Aging Cell. He is the recipient of the Nathan Shock Award, the AlliedSignal Award, the Irving Wright Award, an award from the Glenn Foundation, and the Kleemeier Award for aging research, and was a Senior Scholar of the Ellison Medical Foundation. 

 

He is a Fellow of the American Association for the Advancement of Science, and a Member of the Association of American Physicians. At Michigan, he directs the Geriatrics Center's Biogerontology program, and the Paul F. Glenn Center for Aging Research.

 

His research program includes ongoing studies of the mechanisms that link stress, nutrients, and hormones to delayed aging in mice, and works to develop new approaches to slow aging and disease through drugs, early life dietary restriction, and targeted mutations. He also studies the ways in which cells from long-lived birds, rodents, and primates may differ from those of short-lived species.

Phil Newman

Founder & CEO, Longevity.Technology

 

Phil Newman is Founder and CEO of www.Longevity.Technology, the leading media and consumer brand supporting the longevity megatrend.

 

In his career he has held multiple C-level management positions; applying his marketing and business development expertise into: longevity, IoT, bionics, medical devices, biopharma, 3D manufacturing, smartgrid and sustainability.

 

In 2018 he saw an opportunity in the emerging longevity field to create a media platform that addressed science, business and investment activity. Launched in 2019, www.longevity.technology rapidly became the leading news service with unparalleled domain authority enabling the company to expand its reach into investment, education and ecommerce.

Phil Newman.jpg
Zhao Wang

Zhao Wang

Senior Professor, School of Pharmaceutical Sciences, Tsinghua University

Prof. Zhao Wang is currently a Senior Professor in the School of Pharmaceutical Sciences at Tsinghua University, a member of the Scientific Committee of Aging and Anti-aging of the Chinese Gerontological Society, a Standing Member of Chinese Association of Traditional Chinese Medicine Branch, and a reviewer of the National Natural Science Foundation of China. Besides, he serves as a member of editorial board of Journal of Pharmacological Sciences and Food Science and Human Wellness. He has worked on studying of aging and aging related diseases as well as their biological mechanisms, with a focus on neuropharmacology and metabolic pharmacology, especially the pharmacology related with brain aging, bone aging and degenerative diseases such as AD and osteoporosis. Prof. Wang has published over 200 research articles, reviews and book chapters, and made many academic presentations in related conferences.

Updated on June 19 2024, with more guests being invited continuously

bottom of page